Liver tumor
Conditions
Interventions
Control group:None
Experimental group:0.3% Ropivacaine (16mL) was applied to each side of paravertebral nerve block
Sponsors
Nanchong Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ASA I-III patients aged 18-65 years, BMI <30Kg/m^2, underwent laparoscopic liver tumor resection.
Exclusion criteria
Exclusion criteria: 1. Failure or refusal to provide informed consent; 2. Emergency surgery or secondary surgery; 3. Postoperative transfer to intensive care unit (ICU) is expected; 4. Cerebrovascular accident, myocardial infarction or unstable angina in the previous 3 months; 5. History of depression or mental illness; 6. History of chronic pain or opioid/NSaids treatment before surgery; 7. Block site infection; 8. Combined with peripheral nerve disease; 9. Abnormal coagulation function; 10. Poorly controlled or untreated hypertension (e.g., preoperative resting systolic/diastolic blood pressure >=180/100 mmHg); 11. Severe liver or kidney dysfunction; 12. Allergy to any investigational drug; Alcohol or drug abuse; 13. Participated in another study within the past 30 days; And other conditions that do not apply to paravertebral block.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| adrenaline;surgical situation;medication status;awakening;pain conditions;recovery;side reaction occurrence; | — |
Primary
| Measure | Time frame |
|---|---|
| albumin;prealbumin;C-reactive protein;norepinephrine, NE; | — |
Countries
China
Contacts
Public ContactDu Yu
Nanchong Central Hospital
Outcome results
None listed